FindTrial
Sign In

To check the efficacy of Giloy (Tinospora-Cordifolia) extract in treating Oral Sub-mucous Fibrosis. (OSMF)

Formulation & Optimization Of Tinospora-Cordifolia Extract And Its Efficacy And Safety For The Treatment Of Oral Sub-mucous Fibrosis - A Quasi-Randomized Trial. - Tinospora-Cordifolia extract

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079522
Enrollment
60
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z19-Z19- Hormone sensitivity malignancy status

Interventions

None listed

Sponsors

Trial Investigator
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed OSMF patient, healthy individuals without any systemic diseases, patients who are ready to quit the habit and accept regular follow-up protocol, and patients willing to register for the study with written consent will be included in the study

Exclusion criteria

Exclusion criteria: Patients who have taken treatment for OSMF in last 6 months, pregnant women, patients whose mouth opening was less than or equal to 10 mm (i.e., stage C)

Design outcomes

Primary

MeasureTime frame
Potential treatment for the prevention of oral cancer may be found.Timepoint: 6 months from the day of the first dose.—

Secondary

MeasureTime frame
At the end of project, a potential treatment for prevention of oral cancer may be found.Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Akhil Pratap Singh

S.N. Medical College

dr.akhilpratapsingh1@gmail.com7895484858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026